{"trigger": ["Potent and stable attenuation of live-HIV-1 by gain of a proteolysis - resistant inhibitor of NF-kappaB ( <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_1> S32 / 36A ) and the implications for vaccine development .", "Potent and stable attenuation of live-HIV-1 by gain of a <extra_id_0> proteolysis <extra_id_2> Protein_catabolism <extra_id_1> - resistant inhibitor of NF-kappaB ( IkappaB-alpha S32 / 36A ) and the implications for vaccine development ."], "relation": [["Potent and stable attenuation of live-HIV-1 by gain of a <extra_id_0> proteolysis <extra_id_2> Protein_catabolism <extra_id_1> - resistant inhibitor of NF-kappaB ( IkappaB-alpha S32 / 36A ) and the implications for vaccine development .", "Potent and stable attenuation of live-HIV-1 by gain of a proteolysis - resistant inhibitor of NF-kappaB ( <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> S32 / 36A ) and the implications for vaccine development ."]]}
{"trigger": ["Live - attenuated human immunodeficiency viruses ( HIVs ) are candidates for Acquired Immunodeficiency Syndrome ( AIDS ) vaccine .", "Live - attenuated human immunodeficiency viruses ( HIVs ) are candidates for Acquired Immunodeficiency Syndrome ( AIDS ) vaccine ."], "relation": []}
{"trigger": ["Based on the simian immunodeficiency virus ( SIV ) model for AIDS , loss - of-function ( e.g . deletion of accessory genes such as <extra_id_0> nef <extra_id_2> Protein <extra_id_1> ) has been forwarded as a primary approach for creating enfeebled , but replication-competent , HIV-1 / SIV .", "Based on the simian immunodeficiency virus ( SIV ) model for AIDS , loss - of-function ( e.g . deletion of accessory genes such as nef ) has been forwarded as a primary approach for creating enfeebled , but replication-competent , HIV-1 / SIV ."], "relation": []}
{"trigger": ["Regrettably , recent evidence suggests that loss - of-function alone is not always sufficient to prevent the emergence of virulent mutants .", "Regrettably , recent evidence suggests that loss - of-function alone is not always sufficient to prevent the emergence of virulent mutants ."], "relation": []}
{"trigger": ["New strategies that attenuate via mechanisms distinct from loss - of-function are needed for enhancing the safety phenotype of viral genome .", "New strategies that attenuate via mechanisms distinct from loss - of-function are needed for enhancing the safety phenotype of viral genome ."], "relation": []}
{"trigger": ["Here , we propose gain-of - function to be used simultaneously with loss - of-function as a novel approach for attenuating HIV-1 .", "Here , we propose gain-of - function to be used simultaneously with loss - of-function as a novel approach for attenuating HIV-1 ."], "relation": []}
{"trigger": ["We have constructed an HIV-1 genome carrying the cDNA of a proteolysis - resistant nuclear factor-kappaB inhibitor ( <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_1> S32 / 36A ) in the <extra_id_0> nef <extra_id_2> Protein <extra_id_1> region .", "We have constructed an HIV-1 genome carrying the cDNA of a <extra_id_0> proteolysis <extra_id_2> Protein_catabolism <extra_id_1> - <extra_id_0> resistant <extra_id_2> Negative_regulation <extra_id_1> nuclear factor-kappaB inhibitor ( IkappaB-alpha S32 / 36A ) in the nef region ."], "relation": [["We have constructed an HIV-1 genome carrying the cDNA of a <extra_id_0> proteolysis <extra_id_2> Protein_catabolism <extra_id_1> - resistant nuclear factor-kappaB inhibitor ( IkappaB-alpha S32 / 36A ) in the nef region .", "We have constructed an HIV-1 genome carrying the cDNA of a proteolysis - resistant nuclear factor-kappaB inhibitor ( <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> S32 / 36A ) in the nef region ."], ["We have constructed an HIV-1 genome carrying the cDNA of a proteolysis - <extra_id_0> resistant <extra_id_2> Negative_regulation <extra_id_1> nuclear factor-kappaB inhibitor ( IkappaB-alpha S32 / 36A ) in the nef region .", "We have constructed an HIV-1 genome carrying the cDNA of a <extra_id_0> proteolysis <extra_id_2> Protein_catabolism <extra_id_2> Theme <extra_id_1> - resistant nuclear factor-kappaB inhibitor ( IkappaB-alpha S32 / 36A ) in the nef region ."]]}
{"trigger": ["HIV-1 expressing <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_1> S32 / 36A down-regulates viral expression and is highly attenuated in both Jurkat and peripheral blood mononuclear cells .", "HIV-1 <extra_id_0> expressing <extra_id_2> Gene_expression <extra_id_1> IkappaB-alpha S32 / 36A down-regulates viral expression and is highly <extra_id_0> attenuated <extra_id_2> Negative_regulation <extra_id_1> in both Jurkat and peripheral blood mononuclear cells ."], "relation": [["HIV-1 <extra_id_0> expressing <extra_id_2> Gene_expression <extra_id_1> IkappaB-alpha S32 / 36A down-regulates viral expression and is highly attenuated in both Jurkat and peripheral blood mononuclear cells .", "HIV-1 expressing <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> S32 / 36A down-regulates viral expression and is highly attenuated in both Jurkat and peripheral blood mononuclear cells ."], ["HIV-1 expressing IkappaB-alpha S32 / 36A down-regulates viral expression and is highly <extra_id_0> attenuated <extra_id_2> Negative_regulation <extra_id_1> in both Jurkat and peripheral blood mononuclear cells .", "HIV-1 <extra_id_0> expressing <extra_id_2> Gene_expression <extra_id_2> Theme <extra_id_1> IkappaB-alpha S32 / 36A down-regulates viral expression and is highly attenuated in both Jurkat and peripheral blood mononuclear cells ."]]}
{"trigger": ["We provide formal proof that the phenotypic and attenuating characteristics of <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_1> S32 / 36A permit its stable maintenance in a live , replicating HIV-1 despite 180 days of forced ex vivo passaging in tissue culture .", "We provide formal proof that the phenotypic and attenuating characteristics of IkappaB-alpha S32 / 36A permit its stable <extra_id_0> maintenance <extra_id_2> Positive_regulation <extra_id_1> in a live , replicating HIV-1 despite 180 days of forced ex vivo passaging in tissue culture ."], "relation": [["We provide formal proof that the phenotypic and attenuating characteristics of IkappaB-alpha S32 / 36A permit its stable <extra_id_0> maintenance <extra_id_2> Positive_regulation <extra_id_1> in a live , replicating HIV-1 despite 180 days of forced ex vivo passaging in tissue culture .", "We provide formal proof that the phenotypic and attenuating characteristics of <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> S32 / 36A permit its stable maintenance in a live , replicating HIV-1 despite 180 days of forced ex vivo passaging in tissue culture ."]]}
{"trigger": ["As compared with other open-reading frames embedded into HIV / SIV genome , this degree of stability is unprecedented .", "As compared with other open-reading frames embedded into HIV / SIV genome , this degree of stability is unprecedented ."], "relation": []}
{"trigger": ["Thus , <extra_id_0> IkappaB-alpha <extra_id_2> Protein <extra_id_1> S32 / 36A offers proof-of-principle that artifactually gained functions , when used to attenuate the replication of live HIV-1 , can be stable .", "Thus , IkappaB-alpha S32 / 36A offers proof-of-principle that artifactually gained functions , when used to attenuate the replication of live HIV-1 , can be stable ."], "relation": []}
{"trigger": ["These findings illustrate gain-of - function as a feasible strategy for developing safer live - attenuated HIVs to be tested as candidates for AIDS vaccine .", "These findings illustrate gain-of - function as a feasible strategy for developing safer live - attenuated HIVs to be tested as candidates for AIDS vaccine ."], "relation": []}
